NPPB and Hepatic fibrosis: The fact that MASLD predicts incident HF,4 but also blunts the association between liver fibrosis and NT-proBNP levels and its ability to predict mortality, suggests that MASLD can promote HF development because of metabolic inflammation, but once cardiac changes have occurred, congestive hepatopathy resulting from HF could take over the prognosis.